Results 71 to 80 of about 6,115 (159)

Effects of Mesalamine Combined with Live Combined Bifidobacterium, Lactobacillus and Enterococcus Capsules on Intestinal Mucosa Barrier Function and Intestinal Microbiota in Mildly Active Crohn’s Disease Patients

Journal of Investigative Surgery
Objective: This study is aimed at investigating the impact of mesalamine combined with Live combined Bifidobacterium, Lactobacillus and Enterococcus capsules on intestinal mucosa barrier function and intestinal microbiota in mildly active Crohn’s disease
Meiqin Shen, Yingqi Shi, Zhenming Ge, Junbo Qian   +3 more
doaj   +1 more source

Mesalamine: Safe at first look [PDF]

Inflammatory Bowel Diseases, 1999
L J, Saubermann, J L, Wolf
openaire   +2 more sources

Mesalamine Induced Pneumonitis [PDF]

C37. CASE REPORTS IN DRUG INDUCED LUNG DISEASE, 2020
C. Rosse, B. Rai, C. Schmitt
openaire   +1 more source

Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis

Drug Design, Development and Therapy, 2016
Carmen Cuffari,1 David Pierce,2 Bartosz Korczowski,3 Krzysztof Fyderek,4 Heather Van Heusen,5 Stuart Hossack,6 Hong Wan,5 Alena YZ Edwards,7 Patrick Martin5 1Department of Pediatrics, Division of Pediatric Gastroenterology and Nutrition, The Johns ...
Cuffari C, Pierce D, Korczowski B, Fyderek K, Van Heusen H, Hossack S, Wan H, Edwards AY, Martin P   +8 more
doaj  

Balancing Act: Lessons From Comanaging Patients With Inflammatory Bowel Disease and HIV/AIDS. [PDF]

ACG Case Rep J
Cruz Grave E, Paik P, Kim J, Odufalu FD.
europepmc   +1 more source

Real-World Adherence and Relapse Risk in Mesalamine Treatment for Ulcerative Colitis: Insights from a Large Japanese Medical Claims Database. [PDF]

Inflamm Intest Dis
Wada T, Hosomi S, Kobayashi Y, Nakata R, Nishida Y, Maruyama H, Ominami M, Nadatani Y, Fukunaga S, Otani K, Tanaka F, Fujiwara Y.   +11 more
europepmc   +1 more source

Design and biological evaluation of mesalamine-NSAID hybrids targeting the NLRP3 inflammasome: a multi-target strategy for ulcerative colitis therapy. [PDF]

Sci Rep
Yahya M, Safaei-Ghomi J, Haghir-Ebrahimabadi A, Jalali H, Mojtabazadeh H.   +4 more
europepmc   +1 more source

pH-responsive hyaluronic acid-co-poly(acrylic acid) hydrogel scaffolds for modified release of mesalamine; characterization and biosafety evaluation. [PDF]

RSC Adv
Liaqat H, Minhas MU, Badshah SF, Barkat K, Khan S, Chopra S, Chopra H, Alyami EM, Metouekel A, Asrat Mengistie A, Elossaily GM, Shahid M.   +11 more
europepmc   +1 more source

Design and validation of a robust stability-indicating reversed-phase HPLC method for quantification of mesalamine in formulated drug products. [PDF]

BMC Chem
Mishra AS, Vasanthan M.
europepmc   +1 more source

Repurposing minocycline as an added-on treatment for ulcerative colitis patients on mesalamine: a randomized clinical pilot study. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Mashaly AF, Hegazy SK, Bahgat MM.
europepmc   +1 more source